Abstract

Waterford Life Sciences, Washington, DC; 2014; pp. 165 Author: Fishman SM Ignore this book at your peril! The Federation of State Medical Boards (FSMB) lists this as the definitive resource for implementation of its 2013 “Model Policy on the Use of Controlled Substances for the Treatment of Pain” ⇓. Prescription of Schedule II Medications is regulated in the United States by the Drug Enforcement Agency (DEA) of the Department of Justice (DOJ). The DEA web site names 27 “cases against doctors” in 2013 in which there was “…arrest and prosecution of the registrant.” relating to aberrant opioid prescribing ⇓. However, individual state medical boards also administer enforcement and proscription of errant prescribers. For example, the Minnesota Board of Medical Practice (MBMP) has restricted the licenses of certain practitioners for Schedule II prescribing anomalies. That Board requires knowledge of this specific publication as a condition of relicensure ⇓. The author of this book is a highly respected …

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.